Image

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

EASi-PROTKT™: Testing Vicadrostat with Empagliflozin for type 2 diabetes patients.

Recruiting
18 years and older
All
Phase 3
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study is for adults with type 2 diabetes, high blood pressure, and heart problems, but not heart failure. The study tests if a drug called vicadrostat, taken with empagliflozin, can help lower heart risks. Participants are split into two groups randomly: one takes the actual medicine, and the other takes a placebo (a fake pill that looks real but doesn't have any medicine). Everyone continues their regular medication.

The study lasts up to 4 years and 3 months. Participants take one tablet daily and visit the study site regularly for check-ups and blood tests. Doctors monitor for heart events and any side effects.

  • Study Duration: Up to 4 years and 3 months with regular visits.
  • Participation: Random assignment to medication or placebo. Continue current medications.
  • Eligibility: Must be 18+, with diabetes, high blood pressure, and heart disease, but no heart failure.
Print
Study details
    Diabetes Mellitus
    Type 2
    Hypertension
    Cardiovascular Diseases

NCT07064473

Boehringer Ingelheim

4 April 2026

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Race
Ethnicity
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.